NKGen Biotech, Inc. (GFOR-WT) Financial Statements
NKGen Biotech, Inc. (GFOR-WT) files with the U.S. Securities and Exchange Commission under CIK 0001845459. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2024
- Net Income
- -$44.29 million
- Total Assets
- $16.23 million
- Net Cash from Operations
- -$20.88 million
Fiscal year ended Dec 31, 2024. Latest periodic SEC filing: Jan 20, 2026. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for GFOR-WT in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History